Skip to main content
HWAIL PHARM. CO., LTD logo

HWAIL PHARM. CO., LTD — Investor Relations & Filings

Ticker · 061250 ISIN · KR7061250007 KO Manufacturing
Open in API
Filings indexed 273 across all filing types
Latest filing 2024-03-19 Declaration of Voting R…
Country KR South Korea
Listing KO 061250

About HWAIL PHARM. CO., LTD

http://www.hwail.com/

Hwail Pharm. Co., Ltd. is a pharmaceutical company that specializes in the research, development, manufacturing, and distribution of Active Pharmaceutical Ingredients (APIs). The company also provides a range of finished drug formulations, including generic and patented medications, as well as functional health products. A core focus of the organization is maintaining high standards through continuous R&D investment and rigorous quality control processes to develop and produce its pharmaceutical products.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회결과) for Hwail Pharmaceutical. It details the approval of financial statements, dividend resolutions, and the election of directors and auditors. This falls under the category of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it provides the official outcome of shareholder votes at the AGM.
2024-03-19 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details specific changes to the company's board of directors, including the names of the directors, their roles, and the reasons for their appointment or resignation. This falls directly under the category of Board/Management Information.
2024-03-19 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding a change in the company's representative director (CEO). It details the names of the outgoing and incoming directors, the reason for the change (management efficiency), and the date of the board resolution. This falls directly under the category of Board/Management Information (MANG).
2024-03-19 Korean
불성실공시법인미지정 (지정유예)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory announcement from the Korea Exchange regarding the status of a company (Hwail Pharmaceutical) as a 'non-designated' entity for unfair disclosure practices. It details the regulatory decision, the specific grounds (KOSDAQ disclosure regulations), and the outcome of the review process. Since this is a specific regulatory notice regarding compliance and disclosure status that does not fit into financial reporting or corporate action categories, it is classified as a Regulatory Filing (RNS).
2024-03-19 Korean
사업보고서 (2023.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 43rd fiscal year (2023) of Hwail Pharmaceutical Co., Ltd. It contains comprehensive financial and operational information, including company overview, history, capital changes, and governance details. This is the standard Korean regulatory filing equivalent to an Annual Report (10-K). FY 2023
2024-03-11 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal announcement of the submission of an audit report ('감사보고서 제출') by Hwa-il Pharmaceutical. It provides key financial highlights, audit opinions, and financial data tables as required by regulatory disclosure standards. While it contains financial data, it is a summary announcement of the audit report filing rather than the full annual report (10-K) or a standalone audit report document. Following the 'Menu vs Meal' rule, this is a report publication announcement. FY 2023
2024-03-08 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.